Effect of propranolol versus no antiarrhythmic drug on sudden cardiac death, total cardiac death, and total death in patients > or = 62 years of age with heart disease, complex ventricular arrhythmias, and left ventricular ejection fraction > or = 40%

Am J Cardiol. 1994 Aug 1;74(3):267-70. doi: 10.1016/0002-9149(94)90369-7.

Authors

W S Aronow¹, C Ahn, A D Mercando, S Epstein, I Kronzon

Affiliation

¹ Hebrew Hospital Home, Bronx, New York.

PMID: 7518646
DOI: 10.1016/0002-9149(94)90369-7

No abstract available

Publication types

Clinical Trial
Randomized Controlled Trial

MeSH terms

Aged
Aged, 80 and over
Cardiac Complexes, Premature / prevention & control
Death, Sudden, Cardiac / prevention & control*
Echocardiography
Electrocardiography, Ambulatory
Female
Heart Diseases / diagnostic imaging
Heart Diseases / mortality
Humans
Male
Middle Aged
Propranolol / therapeutic use*
Prospective Studies
Stroke Volume
Survival Rate
Tachycardia, Ventricular / prevention & control

Substances

Propranolol